These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 20883705)
41. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells. Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955 [TBL] [Abstract][Full Text] [Related]
42. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents. Hashimoto S; Danks MK; Chatterjee S; Beck WT; Berger NA Oncol Res; 1995; 7(1):21-9. PubMed ID: 7549041 [TBL] [Abstract][Full Text] [Related]
43. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity. Hirota H; Gosky D; Berger NA; Chatterjee S Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894 [TBL] [Abstract][Full Text] [Related]
44. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479 [TBL] [Abstract][Full Text] [Related]
45. Replication-coupled topoisomerase II templates the mitotic chromosome scaffold? Giménez-Abián JF; Clarke DJ Cell Cycle; 2003; 2(3):230-2. PubMed ID: 12734431 [No Abstract] [Full Text] [Related]
46. Differential gene activity visualized on sister chromatids after replication in the presence of 5-azacytidine. Ferraro M; Lavia P Chromosoma; 1985; 91(3-4):307-12. PubMed ID: 2579777 [TBL] [Abstract][Full Text] [Related]
47. The influence of DNA methylation on topoisomerase II activity and its possible link with genomic instability in different cell lines of the syrian hamster. Kirchner S; Schiffmann D; Stopper H Toxicol In Vitro; 1995 Aug; 9(4):519-25. PubMed ID: 20650123 [TBL] [Abstract][Full Text] [Related]
48. S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs. Roszkowski L; Jaszczyk B; Plebańczyk M; Ciechomska M Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614150 [TBL] [Abstract][Full Text] [Related]
49. DNA Methylation of Human Choline Kinase Alpha Promoter-Associated CpG Islands in MCF-7 Cells. Mohamed Sa'dom SAF; Raikundalia S; Shamsuddin S; See Too WC; Few LL Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205960 [TBL] [Abstract][Full Text] [Related]
50. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013 [TBL] [Abstract][Full Text] [Related]
51. Environmental chemical exposures and human epigenetics. Hou L; Zhang X; Wang D; Baccarelli A Int J Epidemiol; 2012 Feb; 41(1):79-105. PubMed ID: 22253299 [TBL] [Abstract][Full Text] [Related]
52. Topoisomerase II: untangling its contribution at the centromere. Porter AC; Farr CJ Chromosome Res; 2004; 12(6):569-83. PubMed ID: 15289664 [TBL] [Abstract][Full Text] [Related]
53. The role of the DNA hypermethylating agent Budesonide in the decatenating activity of DNA topoisomerase II. Orta ML; Domínguez I; Pastor N; Cortés F; Mateos S Mutat Res; 2010 Dec; 694(1-2):45-52. PubMed ID: 20883705 [TBL] [Abstract][Full Text] [Related]
54. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells. Mateos S; Domínguez I; Pastor N; Cantero G; Cortés F Mutat Res; 2005 Oct; 578(1-2):33-42. PubMed ID: 16202795 [TBL] [Abstract][Full Text] [Related]
55. Halogen substitution of DNA protects from poisoning of topoisomerase II that results in DNA double-strand breaks. Cantero G; Mateos S; Pastor N; Cortés F DNA Repair (Amst); 2006 Jun; 5(6):667-74. PubMed ID: 16406738 [TBL] [Abstract][Full Text] [Related]
56. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth. Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604 [TBL] [Abstract][Full Text] [Related]